0.00

100.00% -0.2075

Casi Pharmaceuticals Inc (CASI)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Casi Pharmaceuticals Inc stock is traded at $0.00, with a volume of 0. It is down -100.00% in the last 24 hours and down -100.00% over the past month. CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Previous Close:

$0.2075

Open:

24h Volume:

Relative Volume:

0.00

Market Cap:

$4.26M

Revenue:

$31.56M

Net Income/Loss:

$-46.89M

P/E Ratio:

0.00

EPS:

-3.0329

Net Cash Flow:

$-26.70M

1W Performance:

-100.00%

1M Performance:

-100.00%

6M Performance:

-100.00%

1Y Performance:

-100.00%

1-Day Range:

$0.00

1-Week Range:

$0.00

52-Week Range:

$0.00

$3.09

Casi Pharmaceuticals Inc Stock (CASI) Company Profile

Name

Casi Pharmaceuticals Inc

Sector

Healthcare (1108)

Industry

Biotechnology (619)

Phone

Address

Employee

233

Twitter

Next Earnings Date

2024-11-14

Latest SEC Filings

CASI's Discussions on Twitter

Compare CASI vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CASI Casi Pharmaceuticals Inc	0.00	4.26M	31.56M	-46.89M	-26.70M	-3.0329
VRTX Vertex Pharmaceuticals Inc	430.29	109.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	751.57	79.46B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	780.25	48.52B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	305.54	40.77B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	300.80	33.39B	5.36B	287.73M	924.18M	2.5229

Casi Pharmaceuticals Inc Stock (CASI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-18-21	Initiated	BTIG Research	Buy
Apr-26-21	Initiated	Mizuho	Buy
Oct-23-20	Initiated	Oppenheimer	Outperform
Sep-22-16	Initiated	Maxim Group	Buy
Oct-29-15	Resumed	H.C. Wainwright	Buy
Jun-23-15	Initiated	H.C. Wainwright	Buy

View All

Casi Pharmaceuticals Inc Stock (CASI) Latest News

Apr 23, 2026

CASI Pharmaceuticals (CASI) director reports fully vested option stakes - Stock Titan

Apr 23, 2026

Apr 22, 2026

CASIF Officer Wang Chunhua Files Initial Ownership, April 2026 - Meyka

Apr 22, 2026

Apr 21, 2026

CASI Pharmaceuticals Delays Annual 20-F Filing - TipRanks

Apr 21, 2026

Apr 20, 2026

Director Zeng lists CASI Pharmaceuticals (CASIF) fully vested option holdings - Stock Titan

Apr 20, 2026

CASI Pharmaceuticals Reshapes Medical Leadership Amid U.S. Streamlining Drive - TipRanks

Apr 20, 2026

CASI Pharmaceuticals, Inc. announced that it has received $20 million in funding from ETP Global III Fund LP - marketscreener.com

Apr 20, 2026

Leadership shift at CASI (NASDAQ: CASI) as Global CMO role ends - Stock Titan

Apr 20, 2026

CASI Pharmaceuticals Closes Final US$5 Million Tranche of US$20 Million Convertible Notes - TipRanks

Apr 20, 2026

CASI Pharmaceuticals (OTCQB: CASIF) completes final $5M convertible note - Stock Titan

Apr 20, 2026

Apr 17, 2026

CASI (CASIF) General Counsel discloses vested and performance-based stock options - Stock Titan

Apr 16, 2026

Apr 15, 2026

CASI Pharmaceuticals Begins Trading on OTCQB Under Ticker CASIF - TipRanks

Apr 15, 2026

CASI Pharmaceuticals (CASI) begins OTCQB trading of ordinary shares as CASIF - Stock Titan

Apr 15, 2026

Apr 13, 2026

CASI Pharmaceuticals (OTC: CASIF) controller reports multiple stock option grants - Stock Titan

Apr 13, 2026

Apr 10, 2026

CASIF Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Apr 10, 2026

Apr 07, 2026

CASI Pharmaceuticals (CASIF) executive details 2034 stock option positions - Stock Titan

Apr 07, 2026

Apr 03, 2026

[Form 3] CASI Pharmaceuticals, Inc. Initial Statement of Beneficial Ownership - Stock Titan

Apr 03, 2026

CASI Pharmaceuticals (CASIF) CMO holds 116,333 fully vested options at $1.93 - Stock Titan

Apr 03, 2026

Apr 02, 2026

CASIF: CASI Pharmaceuticals Inc.Comparison to Industry - Zacks Investment Research

Apr 02, 2026

All News for CASIF : CASI Pharmaceuticals Inc. - Zacks Investment Research

Apr 02, 2026

CASI SEC FilingsCasi Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

MSN Money - MSN

Apr 02, 2026

Apr 01, 2026

CASI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 01, 2026

Mar 31, 2026

Dividend HistoryCASI Pharmaceuticals Inc. (CASIF) - Zacks Investment Research

Mar 31, 2026

Mar 30, 2026

Aug Wrap: Can CASI Pharmaceuticals Inc maintain its current growth rate2026 Setups & Accurate Technical Buy Alerts - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Why Is CASI Pharmaceuticals, Inc. (CASIF) Stock Down Today? - Meyka

Mar 29, 2026

Aug Shorts: Whats the profit margin of CASI Pharmaceuticals IncPortfolio Value Report & Capital Efficient Trade Techniques - baoquankhu1.vn

Mar 29, 2026

Diluted net income available to common stockholders of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView

Mar 29, 2026

Mar 27, 2026

CASI (NASDAQ: CASI) director lists fully vested stock options on Form 3 - stocktitan.net

Mar 27, 2026

Mar 25, 2026

Director Alex Wu details CASI (CASIF) vested stock options and shares - Stock Titan

Mar 25, 2026

Mar 24, 2026

What is the current Price Target and Forecast for CASI Pharmaceuticals Inc. (CASIF) - Zacks Investment Research

Mar 24, 2026

Mar 23, 2026

Wei-Wu He and ETP funds update CASI Pharmaceuticals (CASI) 53% stake - Stock Titan

Mar 23, 2026

Mar 20, 2026

CASI Pharmaceuticals to be delisted from Nasdaq, shares to move to OTC market - MSN

Mar 20, 2026

Mar 18, 2026

CASI (NASDAQ: CASI) director He Wei-Wu details share and option stakes - Stock Titan

Mar 18, 2026

CASI Pharmaceuticals (CASI) director James Huang reports initial holdings - Stock Titan

Mar 18, 2026

Mar 17, 2026

What is the long term forecast for CASI Pharmaceuticals Inc stockEarnings Recap Report & Accurate Buy Signal Alerts - baoquankhu1.vn

Mar 17, 2026

CASI PHARMACEUTICALS TO REPORT SECOND QUARTER 2022 FINANCIAL RESULTS AND HOST CONFERENCE CALL AUGUST 12, 2022 - Quantisnow

Mar 17, 2026

CASI PHARMACEUTICALS TO REPORT FIRST QUARTER 2022 FINANCIAL RESULTS AND HOST CONFERENCE CALL MAY 12, 2022 - Quantisnow

Mar 17, 2026

Mar 16, 2026

Total assets of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView

Mar 16, 2026

Mar 06, 2026

Short Squeeze: Can CASI Pharmaceuticals Inc deliver consistent EPS growth2025 Valuation Update & Daily Stock Momentum Reports - baoquankhu1.vn

Mar 06, 2026

Mar 05, 2026

Why Did CASI Stock Plummet 64% Today To Hit An All-Time Low? - Stocktwits

Mar 05, 2026

Mar 04, 2026